Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECIGEN, INC. Regulatory Filings 2021

Jun 15, 2021

32044_rns_2021-06-15_0067768c-210b-49f2-8401-fc56bd9ab4f1.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 10, 2021


Precigen, Inc.

(Exact name of registrant as specified in its charter)


Virginia 001-36042 26-0084895
(State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)
20374 Seneca Meadows Parkway 20876
Germantown , Maryland (Zip Code)
(Address of principal executive offices)

(Registrant’s telephone number, including area code): ( 301 ) 556-9900

N/A

(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Name of each exchange
Symbol(s) on which registered
Common stock, no par value per share PGEN Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Field: Page; Sequence: 1

Field: /Page

Item 5.07. Submission of Matters to a Vote of Security Holders.

On June 10, 2021, Precigen, Inc. (the “Company”) held the 2021 Annual Meeting of Shareholders (the “2021 Annual Meeting”). At the 2021 Annual Meeting, the Company’s shareholders (i) elected each of the persons listed below as a director for a one-year term, (ii) ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021, (iii) approved a non-binding advisory resolution approving the compensation of the named executive officers, and (iv) approved, on a non-binding advisory basis, the option of “1 Year” for the frequency of future advisory votes on executive compensation (“say-on-pay frequency”).

Proposal 1 –Election of Directors

For Against Abstain Broker Non-Votes
Randal Kirk 123,443,031 1,347,415 211,303 24,789,293
Cesar Alvarez 112,283,265 12,344,274 374,210 24,789,293
Steven Frank 122,849,426 1,778,052 374,271 24,789,293
Vinita Gupta 122,770,179 1,864,773 366,797 24,789,293
Fred Hassan 117,139,798 7,547,318 314,633 24,789,293
Jeffrey Kindler 117,094,661 7,589,561 317,527 24,789,293
Dean Mitchell 112,491,976 12,128,849 380,924 24,789,293
Helen Sabzevari 123,621,626 1,271,534 108,589 24,789,293
Robert Shapiro 123,051,202 1,645,803 304,744 24,789,293
James Turley 115,194,166 9,428,537 379,046 24,789,293

Proposal 2 – Ratification of the Appointment of Deloitte & Touche LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2021.

For Against Abstain Broker Non-Votes
149,358,863 260,595 171,584

Proposal 3 – Non-binding Advisory Resolution Approving the Compensation of the Named Executive Officers.

For Against Abstain Broker Non-Votes
101,077,690 23,552,337 371,722 24,789,293

Proposal 4 – Non-binding Advisory Resolution Approving the Frequency of Future Advisory Votes on the Compensation of Named Executive Officers.

1 Year 2 Years 3 Years Abstain
123,061,586 143,650 637,234 1,159,279

The Company has considered the outcome of this advisory vote and has determined, as was recommended with respect to this proposal by the Company’s board of directors in the proxy statement for the 2021 Annual Meeting, that the Company will hold future say on pay votes on an annual basis until the occurrence of the next advisory vote on the frequency of say on pay votes. The next advisory vote regarding the frequency of say on pay votes is required to occur no later than the Company’s 2027 Annual Meeting of Shareholders.

Field: Page; Sequence: 2

Field: /Page

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number Description
104 Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL document

Field: Page; Sequence: 3

Field: /Page

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| /s/

Donald P. Lehr
Name: Donald
P. Lehr
Title: Chief Legal
Officer

Field: Page; Sequence: 4; Options: Last

Field: /Page